skip to Main Content

Ronald L. Korn, M.D., PhD., founder and CEO of Imaging Endpoints

Ron Korn, M.D. of Imaging Endpoints was recently asked about his team’s work toward the integration of imagery into drug discovery and development. While full integration is a thing of the future, the use of imagery in drug discovery and development can lend significant insights into the biology and efficacy of a drug.

Back To Top